Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Anna Durbin

1-50 of 84 results

View this query on the Wikidata Query Service
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

scientific article
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria

scientific article
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

scientific article (publication date: 9 May 2008)
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

scientific article published in May 2005
A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus

scientific article
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

scientific article
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

scientific article published on March 16, 2016
Dengue viruses cluster antigenically but not as discrete serotypes

scientific article published on September 2015
The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes

scientific article
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

scientific article
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial

scientific article published on 17 January 2013
Prior Dengue virus exposure shapes T cell immunity to Zika virus in humans

scientific article published on 4 October 2017
rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

scientific article published on 27 January 2005
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine

scientific article published on July 21, 2011
The dengue vaccine pipeline: Implications for the future of dengue control

scientific article published on May 16, 2015
rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults

scientific article published on 5 November 2006
Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults

scientific article (publication date: 22 January 2010)
Development of a live attenuated dengue virus vaccine using reverse genetics

scientific article
The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers

scientific article published on 24 July 2006
Dengue vaccine candidates in development

scientific article published on January 2010
The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals

scientific article
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

scientific article
Status of vaccine research and development of vaccines for dengue

scientific article published on 10 March 2016
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults

scientific article
Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics

scientific article published on 22 March 2013
Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies

scientific article published on July 1, 2015
Report of an NIAID workshop on dengue animal models

scientific article
Next-Generation Dengue Vaccines: Novel Strategies Currently Under Development

scientific article published on September 26, 2011
A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial

scientific article published on August 2, 2011
Mechanism and significance of cell type-dependent neutralization of flaviviruses

scientific article
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination

scientific article (publication date: May 2017)
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals

scientific article published on 15 May 2009
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination

scientific article (publication date: 28 December 2016)
An update on Zika vaccine developments

scientific article published on 21 June 2017
Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria

scientific article
Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas

scientific article published on 13 October 2017
Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificity

scientific article (publication date: 14 December 2016)
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity

scientific article
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response

scientific article
Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation

scientific article published on 06 April 2013
The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein

scientific article
Antibody responses to Zika virus infections in flavivirus-endemic environments

scientific article (publication date: 22 February 2017)
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers

scientific article published on August 19, 2013
Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge

scientific article published on 22 March 2006
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers

scientific article (publication date: November 2009)
Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data

scientific article
Vaccine Development for Zika Virus-Timelines and Strategies

scientific article published on 8 September 2016
Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic

scientific article published on December 14, 2010
Antigenic relationships between sylvatic and endemic dengue viruses.

scientific article
Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis

scientific article

Paulina is supported by:

About Paulina

Help